| CD25 and TGF-beta blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer | |
| Pu, Ning; Zhao, Guochao; Yin, Hanlin; Li, Jian-ang; Nuerxiati, Abulimiti; Wang, Dansong; Xu, Xuefeng; Kuang, Tiantao; Jin, Dayong; Lou, Wenhui | |
| 刊名 | JOURNAL OF TRANSLATIONAL MEDICINE
 |
| 2018 | |
| 卷号 | 16 |
| 关键词 | Pancreatic ductal adenocarcinoma Immunotherapy Integrated immune ratio Regulatory T cell Program death receptor-1 |
| ISSN号 | 1479-5876 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3609779 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Pu, Ning,Zhao, Guochao,Yin, Hanlin,et al. CD25 and TGF-beta blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer[J]. JOURNAL OF TRANSLATIONAL MEDICINE,2018,16. |
| APA | Pu, Ning.,Zhao, Guochao.,Yin, Hanlin.,Li, Jian-ang.,Nuerxiati, Abulimiti.,...&Wu, Wenchuan.(2018).CD25 and TGF-beta blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.JOURNAL OF TRANSLATIONAL MEDICINE,16. |
| MLA | Pu, Ning,et al."CD25 and TGF-beta blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer".JOURNAL OF TRANSLATIONAL MEDICINE 16(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论